Cargando…
Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up
AIM: To report on outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) in eyes with pseudoexfoliative glaucoma (PXG). METHODS: Prospective, interventional, non-comparative case series. A total of 103 eyes from 84 patients with PXG were enrolled to undergo a 360-degree ab interno trabecu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237193/ https://www.ncbi.nlm.nih.gov/pubmed/32727734 http://dx.doi.org/10.1136/bjophthalmol-2020-315954 |
_version_ | 1783714681115901952 |
---|---|
author | Sharkawi, Eamon Lindegger, Daniel Josef Artes, Paul H Lehmann-Clarke, Lydia El Wardani, Mohamad Misteli, Marie Pasquier, Jérôme Guarnieri, Adriano |
author_facet | Sharkawi, Eamon Lindegger, Daniel Josef Artes, Paul H Lehmann-Clarke, Lydia El Wardani, Mohamad Misteli, Marie Pasquier, Jérôme Guarnieri, Adriano |
author_sort | Sharkawi, Eamon |
collection | PubMed |
description | AIM: To report on outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) in eyes with pseudoexfoliative glaucoma (PXG). METHODS: Prospective, interventional, non-comparative case series. A total of 103 eyes from 84 patients with PXG were enrolled to undergo a 360-degree ab interno trabeculotomy with gonioscopic assistance using either a 5.0 polypropylene suture or an illuminated microcatheter with up to 24 months of follow-up. Main outcome measures were intraocular pressure (IOP), number of antiglaucoma medications, success rate (IOP reduction ≥20% from baseline or IOP between 6 and 21 mm Hg, without further glaucoma surgery) and complication rate. RESULTS: Mean preoperative IOP was 27.1 mm Hg (95% CI 25.5 to 28.7) using 2.9 (SD 1.1) glaucoma medications which decreased postoperatively to 13.0 mm Hg (95% CI 11.5 to 14.4) and 1.0 (SD 1.1) medications at 24 months (p<0.001). Success rate was 89.2% at 24 months of follow-up, and complication rate was 2.9%. CONCLUSION: At 24 months of follow-up, our results for GATT in PXG demonstrate that this conjunctival sparing procedure effectively lowers IOP and reduces the medications with a low complication rate, in this relatively aggressive glaucoma subtype. |
format | Online Article Text |
id | pubmed-8237193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82371932021-07-09 Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up Sharkawi, Eamon Lindegger, Daniel Josef Artes, Paul H Lehmann-Clarke, Lydia El Wardani, Mohamad Misteli, Marie Pasquier, Jérôme Guarnieri, Adriano Br J Ophthalmol Clinical Science AIM: To report on outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) in eyes with pseudoexfoliative glaucoma (PXG). METHODS: Prospective, interventional, non-comparative case series. A total of 103 eyes from 84 patients with PXG were enrolled to undergo a 360-degree ab interno trabeculotomy with gonioscopic assistance using either a 5.0 polypropylene suture or an illuminated microcatheter with up to 24 months of follow-up. Main outcome measures were intraocular pressure (IOP), number of antiglaucoma medications, success rate (IOP reduction ≥20% from baseline or IOP between 6 and 21 mm Hg, without further glaucoma surgery) and complication rate. RESULTS: Mean preoperative IOP was 27.1 mm Hg (95% CI 25.5 to 28.7) using 2.9 (SD 1.1) glaucoma medications which decreased postoperatively to 13.0 mm Hg (95% CI 11.5 to 14.4) and 1.0 (SD 1.1) medications at 24 months (p<0.001). Success rate was 89.2% at 24 months of follow-up, and complication rate was 2.9%. CONCLUSION: At 24 months of follow-up, our results for GATT in PXG demonstrate that this conjunctival sparing procedure effectively lowers IOP and reduces the medications with a low complication rate, in this relatively aggressive glaucoma subtype. BMJ Publishing Group 2021-07 2020-07-29 /pmc/articles/PMC8237193/ /pubmed/32727734 http://dx.doi.org/10.1136/bjophthalmol-2020-315954 Text en © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Science Sharkawi, Eamon Lindegger, Daniel Josef Artes, Paul H Lehmann-Clarke, Lydia El Wardani, Mohamad Misteli, Marie Pasquier, Jérôme Guarnieri, Adriano Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up |
title | Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up |
title_full | Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up |
title_fullStr | Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up |
title_full_unstemmed | Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up |
title_short | Outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up |
title_sort | outcomes of gonioscopy-assisted transluminal trabeculotomy in pseudoexfoliative glaucoma: 24-month follow-up |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237193/ https://www.ncbi.nlm.nih.gov/pubmed/32727734 http://dx.doi.org/10.1136/bjophthalmol-2020-315954 |
work_keys_str_mv | AT sharkawieamon outcomesofgonioscopyassistedtransluminaltrabeculotomyinpseudoexfoliativeglaucoma24monthfollowup AT lindeggerdanieljosef outcomesofgonioscopyassistedtransluminaltrabeculotomyinpseudoexfoliativeglaucoma24monthfollowup AT artespaulh outcomesofgonioscopyassistedtransluminaltrabeculotomyinpseudoexfoliativeglaucoma24monthfollowup AT lehmannclarkelydia outcomesofgonioscopyassistedtransluminaltrabeculotomyinpseudoexfoliativeglaucoma24monthfollowup AT elwardanimohamad outcomesofgonioscopyassistedtransluminaltrabeculotomyinpseudoexfoliativeglaucoma24monthfollowup AT mistelimarie outcomesofgonioscopyassistedtransluminaltrabeculotomyinpseudoexfoliativeglaucoma24monthfollowup AT pasquierjerome outcomesofgonioscopyassistedtransluminaltrabeculotomyinpseudoexfoliativeglaucoma24monthfollowup AT guarnieriadriano outcomesofgonioscopyassistedtransluminaltrabeculotomyinpseudoexfoliativeglaucoma24monthfollowup |